Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice

被引:56
|
作者
Mok, H
Jelinek, J
Pai, S
Cattanach, BM
Prchal, JT
Youssoufian, H
Schumacher, A [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England
来源
DEVELOPMENT | 2004年 / 131卷 / 08期
关键词
ferroportin; 1; iron homeostasis; hepcidin;
D O I
10.1242/dev.01081
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Coding region mutations in the principal basolateral iron transporter of the duodenal enterocyte, ferroportin 1 (FPN1), lead to autosomal dominant reticuloendothelial iron overload in humans. We report the positional cloning of a hypermorphic, regulatory mutation in Fpn1 from radiation-induced polycythaemia (Pcm) mice. A 58 bp microdeletion in the Fpn1 promoter region alters transcription start sites and eliminates the iron responsive element (IRE) in the 5' untranslated region, resulting in increased duodenal and hepatic Fpn1 protein levels during early postnatal development. Pcm mutants, which are iron deficient at birth, exhibited increased Fpn1-mediated iron uptake and reticuloendothelial iron overload as young adult mice. Additionally, Pcm mutants displayed an erythropoietin (Epo)-dependent polycythemia in heterozygotes and a. hypochromic, microcytic anemia in homozygotes. Interestingly, both defects in erythropoiesis were transient, correcting by young adulthood. Delayed upregulation of the negative hormonal regulator of iron homeostasis, hepcidin (Hamp), during postnatal development correlates strongly with profound increases in Fpn1 protein levels and polycythemia in Pcm heterozygotes. Thus, our data suggest that a Hamp-mediated regulatory interference alleviates the defects in iron homeostasis and transient alterations in erythropoiesis caused by a regulatory mutation in Fpn1.
引用
收藏
页码:1859 / 1868
页数:10
相关论文
共 50 条
  • [1] Brain and retinal ferroportin 1 dysregulation in polycythaemia mice
    Lacovelli, Jared
    Mlodnicka, Agnieska E.
    Veldman, Peter
    Ying, Gui-Shuang
    Dunaief, Joshua L.
    Schumacher, Armin
    [J]. BRAIN RESEARCH, 2009, 1289 : 85 - 95
  • [2] Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice
    Mok, H
    Mendoza, M
    Prchal, JT
    Balogh, P
    Schumacher, A
    [J]. DEVELOPMENT, 2004, 131 (19): : 4871 - 4881
  • [3] ERYTHROPOIESIS AND IRON HOMEOSTASIS IN MICE AND HUMANS WITH MUTATED DMT1
    Zidova, Zuzana
    Kapralova, Katarina
    Dolezal, Dalibor
    Luzna, Pavla
    Divoky, Vladimir
    Horvathova, Monika
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E150 - E150
  • [4] Analysis of iron homeostasis in mice with a targeted deletion of the gene encoding the iron exporter Ferroportin 1 (Fpn1).
    Donovan, A
    Lima, C
    Andrews, NC
    [J]. BLOOD, 2003, 102 (11) : 157A - 157A
  • [5] The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
    Donovan, A
    Lima, CA
    Pinkus, JL
    Pinkus, GS
    Zon, LI
    Robine, S
    Andrews, NC
    [J]. CELL METABOLISM, 2005, 1 (03) : 191 - 200
  • [6] Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice
    Ledesma-Colunga, Maria G.
    Baschant, Ulrike
    Fiedler, Imke A. K.
    Busse, Bjoern
    Hofbauer, Lorenz C.
    Muckenthaler, Martina U.
    Altamura, Sandro
    Rauner, Martina
    [J]. BONE, 2020, 137
  • [7] Role of the kidney in iron homeostasis: renal expression of Prohepcidin, Ferroportin, and DMT1 in anemic mice
    Veuthey, Tania
    D'Anna, Maria Cecilia
    Roque, Marta Elena
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (04) : F1213 - F1221
  • [8] Disruption of klotho gene causes an abnormal energy homeostasis in mice
    Mori, K
    Yahata, K
    Mukoyama, M
    Suganami, T
    Makino, H
    Nagae, T
    Masuzaki, H
    Ogawa, Y
    Sugawara, A
    Nabeshima, Y
    Nakao, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) : 665 - 670
  • [9] Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development
    Porter, John
    Taher, Ali
    Viprakasit, Vip
    Kattamis, Antonis
    Coates, Thomas D.
    Garbowski, Maciej
    Durrenberger, Franz
    Manolova, Vania
    Richard, Frank
    Cappellini, M. Domenica
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (07) : 633 - 644
  • [10] DISRUPTION OF THE HEPCIDIN/FERROPORTIN REGULATORY CIRCUITRY CAUSES PULMONARY IRON OVERLOAD AND RESTRICTIVE LUNG DISEASE
    Neves, Joana
    Leitz, Dominik
    Brandenberger, Christina
    Muehlfeld, Christian
    Agrawal, Raman
    Mall, Marcus A.
    Altamura, Sandro
    Muckenthaler, Martina U.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E255 - E255